Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the Alzheimer’s disease (AD) continuum. Investigating populations with SCD is important for understanding the early pathological mechanisms of AD and identifying SCD-related biomarkers, which are critical for the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqi, Huang, Weijie, Su, Li, Xing, Yue, Jessen, Frank, Sun, Yu, Shu, Ni, Han, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507636/
https://www.ncbi.nlm.nih.gov/pubmed/32962744
http://dx.doi.org/10.1186/s13024-020-00395-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507636/
https://www.ncbi.nlm.nih.gov/pubmed/32962744
http://dx.doi.org/10.1186/s13024-020-00395-3

Ejemplares similares